Phase III, Open-label Study of First-line Osimertinib With or Without Datopotamab Deruxtecan for EGFRm Locally Advanced or Metastatic Non-small Cell Lung Cancer
- Status
- RECRUITING
- Phase
- PHASE3
Clinical Trials Related to Non-small Cell Lung Cancer
Related studies linked through entity extraction aliases.
Survival Validation and Gene Mutations of N Descriptors in the Ninth Edition of the TNM Classification for Lung Cancer
- Status
- RECRUITING
- Phase
- N/A
Sunvozertinib Plus Anlotinib as 1L Treatment in EGFR-Sensitive Mutations Combined With Co-Mutations Advanced NSCLC
- Status
- RECRUITING
- Phase
- PHASE2
A Study of Calderasib (MK-1084) Plus Pembrolizumab (MK-3475) in Participants With KRAS G12C Mutant Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥50% (MK-1084-004/KANDLELIT-004)
- Status
- RECRUITING
- Phase
- PHASE3
Open-label Study of BBO-8520 in Adult Subjects With KRASG12C Non-small Cell Lung Cancer
- Status
- RECRUITING
- Phase
- PHASE1
To Evaluate the Safety and Tolerability of Carbognilumab Combined With Chemotherapy as the First-line Treatment for Patients With KEAP1 Mutated Advanced or Postoperative Recurrent Non-small Cell Lung Cancer (NSCLC)
- Status
- RECRUITING
- Phase
- PHASE2
Anlotinib Combined With Penpulimab as Front-line Treatment in Advanced Non-small Cell Lung Cancer
- Status
- RECRUITING
- Phase
- PHASE2
High-Fermented Food Intervention Among Locally Advanced Rectal Cancer Patients (The FEED Trial)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- NA
Anvumetostat Alone or in Combination With Other Therapies in Subjects With Advanced Thoracic Tumors With Homozygous MTAP-deletion (Master Protocol) (MTAPESTRY 104).
- Status
- RECRUITING
- Phase
- PHASE1
A Study Comparing Sotorasib With Durvalumab in People With Non-Small Cell Lung Cancer (NSCLC)
- Status
- COMPLETED
- Phase
- PHASE2
A Single-arm Pilot Study of First-line Treatment With Carbognilumab Combined With Chemotherapy in Patients With STK11-mutated Advanced or Postoperative Recurrent Non-small Cell Lung Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Effect of Low-dose Radiotherapy on Tumor Immune Microenvironment in Oligometastases of NSCLC After Immunotherapy
- Status
- WITHDRAWN
- Phase
- PHASE2
Anesthesia and Non-small Cell Lung Cancer Recurrence
- Status
- RECRUITING
- Phase
- PHASE4
Assessment of the Safety and Efficacy of Balstilimab in Combination With Botensilimab for the Treatment of Non-Small Cell Lung Cancer (IMMONC0008)
- Status
- RECRUITING
- Phase
- PHASE2
Carbon Ion Radiotherapy for Locally Advanced Lung Cancer in Elderly Patients
- Status
- RECRUITING
- Phase
- PHASE2
FiH Study to Investigate Safety, PK and Efficacy of the NaPi2b ADC TUB-040 in Patients With PROC or r/r Adenocarcinoma NSCLC
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Myeloprotection With Trilaciclib in Pan-cancer Population
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
A Phase II Clinical Trial of DZD9008 in Combination With AZD4205 in Standard Treatment Failed NSCLC Patients With EGFR Mutations (WU-KONG21)
- Status
- RECRUITING
- Phase
- PHASE2
Study of DCC-3084 in Participants With Advanced Malignancies Driven by the Mitogen-Activated Protein Kinase (MAPK) Pathway
- Status
- TERMINATED
- Phase
- PHASE1
Deep Learning Model Predicts Pathological Complete Response of Lung Cancer Following Neoadjuvant Immunochemotherapy
- Status
- NOT_YET_RECRUITING
- Phase
- N/A